MR编号 | CZ/H/0142/002 |
---|
药品名称 | Sibutramine Teva 15 mg tobolky |
---|
活性成分 | - sibutramine hydrochloride 15.0 mg
|
---|
剂型 | Capsule, hard |
---|
上市许可持有人 | TEVA PHARMACEUTICALS CR s.r.o.
Brno
Czech Republic |
---|
参考成员国 - 产品名称 | Czechia (CZ) |
---|
互认成员国 - 产品名称 | - Sweden (SE)
Sibutramine Teva - Germany (DE)
Sibutramin Teva 15 mg Hartkapseln - Belgium (BE)
- Luxembourg (LU)
- United Kingdom (Northern Ireland) (XI)
- France (FR)
- Italy (IT)
- Latvia (LV)
Sibutramine Teva 15 mg cietās kapsulas - Lithuania (LT)
Sibutramine Teva 15 mg kietos kapsulės - Estonia (EE)
- Bulgaria (BG)
Meissa - Romania (RO)
Sibutramină Teva 15 mg capsule - Denmark (DK)
Sibutramin "Teva" - Ireland (IE)
- Spain (ES)
- Portugal (PT)
- Greece (GR)
|
---|
许可日期 | 2008/02/06 |
---|
最近更新日期 | 2024/08/19 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|